Introduction
Invasive therapy for atherosclerotic vascular disease has gradually shifted from surgery to a choice between surgery and angioplasty. Intraluminal stenting with vascular endoprostheses was already attempted in the early days of balloon angioplasty for the treatment of procedure-related complications and the prevention of restenosis.' Narrowing of the stented segment caused by neointimal hyperplasia limited the use of these devices even in the larger (peripheral) arteries. Changes in design, the use of other metal alloys, and miniaturization of the endoprostheses now yielded several stents for experimental and clinical Studies of peripheral and coronary arteries in sheep and dogs have, however, shown that thrombosis still occurs in 20%-30% of the stents, in particular during the first 14 days after implantati~n.~.~ This may be related to the lack of a protective endothelial covering. Thrombosis occurs in these animals between 2 weeks and 3 months after implantation. Effective measures should be taken during the period between implantation and neointimal covering to prevent the incidence of thrombosis. In the present study we show that seeding stents with endothelial cells may be such a measure.
Materials and Methods

In Vitro Endothelialization of Stent
Harvesting endothelium from human umbilical veins. Immediately after delivery the umbilical cord vein was cannulated and flushed with Hepesbuffered saline. Thereafter the vein was filled with medium containing 0.1% collagenase and incubated for 20 min at 37°C. Then the vein was flushed with medium and the cell-suspension collected in plastic tubes. After centrifugation for 5 min at 125 g, the cell pellet was resuspended in Medion M 199 (Flow Laboratories Ltd, Irvine, Scotland) supplemented with serum and growth factors and cultured in a flask coated with fibronectine ( 10 pg/cm2) for 2 day^.^,^ Description of the Stent. The stent used (WallstentR, Medinvent SA, Lausanne, Switzerland) was a stainless-steel, open-weave wire-mesh (Fig.  1) . The prosthesis is self-expanding and its elastic properties are such that its diameter can be substantially reduced by elongation. It can thus be constrained on a small-diameter delivery catheter, which consists of two coaxial catheters, the proximal regions of which are joined by an invaginated rolling membrane, which effectively retains the prosthesis. Withdrawal of the outer catheter rolls back the membrane progressively, thus releasing the stent, which tends to return to its orginal diameter, thereby anchoring itself against the arterial wall. The unconstrained diameter of the stent used in this study was 3.5 mm and the length 15 mm.
Coating the Stents with Endothelium. The unconstrained stents were incubated with fibronectine (100 pg/mL) for 15 min at 37°C for support of endothelial coverage. Endothelial cell suspensions (derived as above) were brought together with the stent in a small siliconized glass tube and rotated (2 rpm) for 2 hours at 37°C. Subsequently, the stent with cells were transferred to a petri dish, covered with medium and cultured overnight. For the coating of 1 cm stent (diameter 3.5 mm) about 50,000 endothelial cells were used. The cells on the stent were stained with the vital DNA-stain Hoechst 33342 (Hoechst AG, Frankfort, FRG) (10 uM; 1 hour; 37°C) or with the vital dye fluorescence diacetate (Serva, Heidelberg, FRG) (0.1 pg/mL, 10 min; 37°C). Other stents were fixed with buffered glutaraldehyde (3%) and stained with the nuclear stain propidium iodide (Sigma, St Louis, MO, USA) (10 pg/mL). The cell-covered stents were observed with a fluorescence microscope with epi-illumination.
Coating the Stents Mounted on the Delivery Catheter. First the fibronectine solution and then the endothelial cell suspension was drained by applying a minimal suction at the central catheter of the stent-loaded delivery system. After sealing the tip of the stent-delivery catheter by a sterile glove covered finger the suspension was advanced through the pores of the central catheter until it had replaced the air around the stent filaments. Then the mounted stent was incubated overnight. The next day the stent was released from the catheter and placed in fluorescent dye (propidium iodide, 10 pg/mL) after fixation in phosphate buffered 3% glutaraldehyde.
In Vivo Endothelialization of Stents. In 6 young
Yorkshire swine (18-25 kg) a total number of 18 stents were implanted. After sedation with 500 mg of ketamine hydrochloride (Aescoket,R Aesculaap BV, Boxtel, Holland) the animals were connected to a respirator for artificial ventilation with a mixture of oxygen and nitrous oxide, after endotracheal intubation. Anesthesia was maintained with 1-4 vol% enflurane (Ethrane,R Abbott BV, Amstelveen, Holland) while pancuronium bromide (PavuloqR Organon, Oss, Holland) was used as a muscle relaxant. An 8F introduction sheath was placed via the left carotid artery in the descending aorta. After intravenous administration of 5,000 IU heparin and 100 mg aspirin (Aspegic.R Lorex, Weesp, Holland), an 8F guiding catheter was advanced to the aorto-iliac bifurcation.
After baseline angiography of both femoral arteries a 300 cm, 0.014 inch long guidewire was placed in the left femoral artery. Over the guidewire an angioplasty balloon catheter (balloon size 3.5 mm) was advanced. From the angiograms, and using the diameter of the guide catheter as a reference, a segment of the left femoral artery was chosen with a diameter of 3.0 mm. At that point the angioplasty balloon was inflated twice for 60 sec and 10 Atm inflation pressure. Then the angio-plasty catheter was withdrawn, and angiography was repeated. The stent constrained delivery catheter, with an endoprosthesis mounted on its tip was positioned over the long guidewire at the dilated arterial segment. After the stent was released, catheters and guidewire were withdrawn to the aortic bifurcation, and repeat angiography was performed. The same procedure was followed for placement of a stent in the right (contralateral) femoral artery, except that at this site angioplasty was not performed. The catheters were removed, and the animals allowed to recover.
Starting the day of the procedure animals 1 and 2 received calciparin 25,000 IU subcutaneously daily until acenocoumarol had prolonged the prothrombin time three-fold. Aspirin 100 m1/24 h intravenously was also added. The other animals received only 100 mg of aspirin in one daily oral dose. After 6 days (animals 1 and 2; 8 stents), 8 days (animals 3-5; 6 stents) and 10 days (animal 6; 4 stents), the animals were again anesthetized, and angiography of the stent-related arteries was performed. Immediately thereafter the stent-containing arterial segments were dissected free, perfused in vivo with saline (perfusion pressure 75 mmHg) and removed. Thereafter the animals were sacrificed with an overdose of pentobarbitone sodium. The stent-containing arterial segments were placed in buffered glutaraldehyde for subsequent electron microscopy.
Electron Microscopy. After fixation in 4% formaldehyde and 1 % glutaraldehyde in 0.1 M cacodylate buffer (pH 7.3) for at least 48 hours, the stent containing arterial segments were washed in cacodylate buffer and divided lengthwise into two equal parts using a pair of fine scissors. One half of the stent underwent postfixation for 6 hours in 1% osmium tetroxide, and washing overnight in distilled water, and dehydration in graded ethanol and critical point drying with liquid C02. This part of each vessel was mounted and sputtercoated with gold before examination in a scanning electron microscope (Cambridge 180 steroscan, Cambridge, U.K.).
From the other half of each vessel the stent wires were removed and the tissue was prepared for light microscopy.
Hematologic Measurements. Before administration of the anticoagulants, at the end of the implantation procedure and again after 2 and 6 days of recovery, 10 mL arterial blood was collected in a syringe containing sodium citrate (final concen- 
Results
In Vitro Endothelialization. Harvesting endothelium from human umbilical cord veins yielded approximately 2.105 cells per vein (10-15 cm). After culturing these cells for 4 days about lo6 cells were available for seeding the stent. Incubation of these cells with the isolated stent for 2 hours and subsequent culturing resulted in an almost complete blanketing of the inner surface of the stent wires by flattened endothelial cells (Fig. 1) .
Fluorescence staining of endothelial nuclei with Hoechst 33342 showed a uniform distribution of the cells on the stent wires (Fig. 2) . Incubation of the stent mounted on the delivery catheter with isolated endothelium for 2 hours resulted in a similar endothelial lining. However, the inner surface proved to be covered for only approximately 50% after the stent had been released.
In Vivo Endothelialization in Porcine Femoral Arteries. All implanted stents remained patent during the period after implantation (6-10 days). Angiograms obtained at the end of the observation period showed no signs of stent-displacement, while stent-related intraluminal defects (considered to be caused by thrombus) could not be demonstrated in any of the implants (Fig. 3) . Scanning electron microscopy showed that the stents were completely covered by an endothelial lining as early as 6 days after implantation (Fig. 4) . No dcposition of platelet aggregates or thrombus material was observed on the neointimal lining. Trans- Figure 5A . Light microscopy of stented porcine femoral artery 3 days after implantation (magnification 190 X). The empty spaces correspond with the stent wires. At the site of the stent filaments the media is considerably compressed, while the internal elastic lamina is interrupted.
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Journal of Interventional Cardiology mission microscopy showed that the stent filaments compressed the arterial media (Fig. 5A) , with disruption of the internal elastic lamina (FigsSA and 5B) . A neointima of varying thickness covered the stent wires. While normal femoral arteries showed a thin intimal layer (5 pm), the median thickness of the stent covering neointima was 80 pm (range 60-125 pm). The neointima was covered with endothelial cells (Fig. 5C ). In the neointima directly underneath the endothelium a mixture of fibers, trapped red blood cells and macrophage-type cells were present (Figs. 5B and 5C). Fibrous material, probably consisting of fibrin, occupied small areas between the stent filament and new intima. The presence of this fibrous material and the entrapped cells suggests that some deposition of thrombotic material might have occurred before the development of the neointima was completed. N o differences in ultrastructural appearance could be demonstrated between arterial segments that had been subjected to balloon angioplasty and those segments which were not dilated.
Hematological Data. The results of the hematological measurements are summarized in Table 1 . During recovery prothrombin time and recalcification time were significantly prolonged in the animals receiving extensive anticoagulant therapy. In the animals receiving only aspirin, these values were normal again 2 days after implantation.
Dissussion
The application of percutaneous transluminal coronary angioplasty (PTCA) for the treatment of coronary artery disease has increased considerably in recent years. The initial success rate is with only a small incidence of acute or subacute occlusion at the site of angiop1a~ty.l~~~~ However, restenosis several months after the procedure remains an unsolved problem with an incidence of 20%-40%.1"'6 The effect of pharmacological therapy on acute complication^'^-^^ and late restenosisZo is still unclear. The implantation of vascular endoprostheses after angioplasty to prevent these Group 1 (animals 1 and 2) received the extensive anticoagulant therapy; group 2 (animals 3-6) received only aspirin after implantation. All data have been presented as mean f SEM.
sequelae in patients with coronary atherosclerosis has proven feasible.2' Whether this technique actually reduces the incidence of restenosis is as yet unknown. Observations in a small number of patients show that the implantation of an endoprosthesis after balloon angioplasty causes an immediate slight further dilatation of the arterial segment.22 However, after 3 months a small but significant diffuse narrowing of the stented artery was observed.23 Implantations of such endoprostheses in peripheral and coronary arteries in sheep and dogs showed early thrombotic complications (< 14 days) in 20%-30%.6,7 This percentage can probably be reduced by avoiding some "thrombogenic" implantation parameters such as diameter mismatch between stent and receiving artery, stent margin at side-branch, low flow through the stented vessel and administration of low doses of aspirin ( 5 mg/kg) after implantation as in the present study. In vascular surgery comparable problems are encountered. Proposed solutions by this discipline comprise the design of nonthrombogenic vascular grafts, or seeding the graft surface with autologous endothelial cells. Cell-seeding might be the better solution, as this provides an active antithrombotic graft surface.24 Metal-alloy vascular endoprostheses currently available share the advantage, contrary to polymer surface vascular grafts, of macroporosity, covering up to 20% of the vascular surface area. This will allow earlier covering of the stent filaments with native endothelium. Endothelial covering was reported after 10 days to 8 weeks dependent upon the species, type of stent, size of receiving vessel and whether or not atherosclerotic lesions were In the present study it was shown that stents placed in porcine femoral arteries were already covered with neointima after 6 days. This faster rate of neointimal generation may be related to age and species of the animals.28Prior balloon angioplasty, which has been shown to cause effective endothelid denudation in the same did not seem to delay this process. The thickness of the neointima in the present study (80 pm) is comparable to data reported by others in the same species 8 weeks after implantati~n,~~Data reported for dog implantations seem more variable. After 1 to 3 weeks mean neointimal thicknesses of 80 to 300 pm have been r e p~r t e d .~,~~.~~ After 6-12 months these values were 270-450 pm.7*27 Although one should be cautious in comparing results obtained in different species with different types of stents, and while most authors do not specify their measurements, the conclusion seems justified that neointimal thickening progresses gradually.
In man endothelial covering of vascular prothesis occurs much slower than in the pig.28 Accordingly the prosthesis is subjected to prothrombotic forces for a longer duration. This might imply the need for chronic antithrombotic treatment or other alternatives. Cell-seeding the stents might be that alternative. In the present study one of the clinically most relevant stents can be covered by endothelial cells in vitro, after relatively simple and nontime consuming measures. Scanning electron microscopy shows that the endothelial cells are flattened with close cell-to-cell contact.
Whether these cells remain attached to the stent after intra-arterial placement depends upon the shear resistance, which has to be studied in further experiments. Furthermore it has to be established whether the cells remain viable and metabolically active, considering the dependence of the cells on endothelial cell growth factor. This dependence might be related to cell density in culture, but more data are needed to establish this. The use of autologous endothelial cell suspensions harvested from subcutaneous fat biopsies, avoids the need for tissue typing and the risk of cell rejection.
In conclusion, our study showed an early timespan wherein endovascular stents were covered by a neointima. Present data suggest that stents are at risk for partial or complete thrombotic occlusion during at least the first 6 days after implantation. Cell-seeding of the stent filaments, to obtain an active antithrombotic stent surface, seems an attractive method to reduce this risk. In vitro experiments demonstrated that stents can be covered by a substantial number of endothelial cells within hours. These data strongly suggest further in vivo experiments to investigate whether this approach may contribute to the solution of a major problem in current cardiologic interventions.
